OncLive | Bringing the Global Oncology Community Together

Jennifer R. Brown, MD, PhD, highlights the new and upcoming research regarding acalabrutinib in the field of chronic lymphocytic leukemia. Read More >>

Quest Continues to Turn NSCLC Into Chronic Disease

ICML 2019: Optimal Upfront Lenalidomide/R-CHOP Use Remains Puzzle in DLBCL

ICML 2019: Maintenance Therapy Remains Challenging Strategy in DLBCL

PSMA Emerges as Versatile Target in Prostate Cancer and Beyond

Novel Combos, Predictive Biomarkers Slated as Future of HCC Treatment

View More Stories >>

View Conference Coverage

2019 State of the Science Summit on Hematologic Malignancies in Pittsburgh

2019 State of the Science Summit on Hematologic Malignancies in Seattle

15th International Conference on Malignant Lymphoma

2019 European Hematology Association Congress

2019 ASCO Annual Meeting

Dr. Gainor on Potential With BLU-667 in RET+ NSCLC

Dr. Rao on Abemaciclib Post-Palbociclib in Metastatic Breast Cancer

Dr. Pecora on Updated MAIA Data in Multiple Myeloma

Dr. Mouw on the Role of Radiation Therapy in Prostate Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Monitoring Response & Initiating Second-Line Therapy in HCL

Approaches to Frontline Therapy in HCL

A Differential Diagnosis of Hairy Cell Leukemia

Hairy Cell Leukemia: Incidence and Presentation

Rationale for Immunotherapy in Ovarian Cancer

Ovarian Cancer: Recurrence After PARP Inhibition

OncLive houses thousands of videos that provide updates and information.
See more Videos

Hepatocellular Carcinoma: AFP's Role as a Biomarker

Progress in the Management of Hepatocellular Carcinoma

Minimizing Adverse Effects of Chemoradiotherapy

Radiation Therapy: Dosing, Scheduling, & Toxicity Management

Radiation Therapy Eligibility for Stage III NSCLC

Management of PARP Inhibitor AEs in Ovarian Cancer

Impact of SOLO-1 on Advanced Ovarian Cancer Management

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

New Directions in Chronic Lymphocytic Leukemia Care: A Review of 2019 Treatment Guideline Updates

Pivotal trial data were presented at the 2018 ASH Annual Meeting that demonstrated promising results for the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (SLL).

View more >>>

Featured

TRK Inhibitors: Precision Medicine in Oncology

Benjamin Levy, MD; Mark Agulnik, MD; Marcia Brose, MD, PhD; Edward Kim, MD; John Marshall, MD; and Philip Agop Philip, MD, PhD, FRCP, discuss the use of TRK inhibitors in oncology.

View more >>>

Featured Video

Advances in BRAF-Targeted Therapy for Metastatic Melanoma

Novel Combination Approaches for Metastatic Kidney Cancer

Geoffrey Thomas Gibney, MD; Ryan J. Sullivan, MD; Hussein A. Tawbi, MD, discuss advances in BRAF-targeted therapy for patients with metastatic melanoma. View now

FDA Approvals in HNSCC and DLBCL, and Encouraging Data in CLL, MDS, and CMML